MOLINA HEALTHCARE INC (MOH) Fundamental Analysis & Valuation

NYSE:MOH • US60855R1005

Current stock price

149.2 USD
+0.01 (+0.01%)
At close:
148.59 USD
-0.61 (-0.41%)
After Hours:

This MOH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MOH Profitability Analysis

1.1 Basic Checks

  • In the past year MOH was profitable.
  • MOH had a negative operating cash flow in the past year.
  • Each year in the past 5 years MOH has been profitable.
  • MOH had a positive operating cash flow in 4 of the past 5 years.
MOH Yearly Net Income VS EBIT VS OCF VS FCFMOH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

1.2 Ratios

  • MOH's Return On Assets of 3.03% is fine compared to the rest of the industry. MOH outperforms 65.35% of its industry peers.
  • The Return On Equity of MOH (11.60%) is better than 78.22% of its industry peers.
  • MOH has a better Return On Invested Capital (7.39%) than 69.31% of its industry peers.
  • MOH had an Average Return On Invested Capital over the past 3 years of 14.32%. This is significantly above the industry average of 8.98%.
  • The last Return On Invested Capital (7.39%) for MOH is well below the 3 year average (14.32%), which needs to be investigated, but indicates that MOH had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.03%
ROE 11.6%
ROIC 7.39%
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
MOH Yearly ROA, ROE, ROICMOH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • MOH has a Profit Margin (1.04%) which is in line with its industry peers.
  • MOH's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 1.73%, MOH is in line with its industry, outperforming 47.52% of the companies in the same industry.
  • MOH's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 13.07%, MOH is doing worse than 67.33% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MOH has declined.
Industry RankSector Rank
OM 1.73%
PM (TTM) 1.04%
GM 13.07%
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
MOH Yearly Profit, Operating, Gross MarginsMOH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MOH Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MOH is creating value.
  • The number of shares outstanding for MOH has been reduced compared to 1 year ago.
  • MOH has less shares outstanding than it did 5 years ago.
  • MOH has a worse debt/assets ratio than last year.
MOH Yearly Shares OutstandingMOH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
MOH Yearly Total Debt VS Total AssetsMOH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • MOH has an Altman-Z score of 4.20. This indicates that MOH is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of MOH (4.20) is better than 79.21% of its industry peers.
  • A Debt/Equity ratio of 0.97 indicates that MOH is somewhat dependend on debt financing.
  • MOH has a Debt to Equity ratio (0.97) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z 4.2
ROIC/WACC0.93
WACC7.92%
MOH Yearly LT Debt VS Equity VS FCFMOH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.69 indicates that MOH should not have too much problems paying its short term obligations.
  • MOH's Current ratio of 1.69 is fine compared to the rest of the industry. MOH outperforms 68.32% of its industry peers.
  • MOH has a Quick Ratio of 1.69. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
  • MOH has a Quick ratio of 1.69. This is in the better half of the industry: MOH outperforms 70.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.69
MOH Yearly Current Assets VS Current LiabilitesMOH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. MOH Growth Analysis

3.1 Past

  • The earnings per share for MOH have decreased strongly by -52.98% in the last year.
  • Measured over the past years, MOH shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.02% on average per year.
  • MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.75%.
  • MOH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.52% yearly.
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%

3.2 Future

  • Based on estimates for the next years, MOH will show a very strong growth in Earnings Per Share. The EPS will grow by 21.69% on average per year.
  • The Revenue is expected to grow by 4.17% on average over the next years.
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue Next Year0%
Revenue Next 2Y3.1%
Revenue Next 3Y3.89%
Revenue Next 5Y4.17%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MOH Yearly Revenue VS EstimatesMOH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
MOH Yearly EPS VS EstimatesMOH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

2

4. MOH Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.01 indicates a correct valuation of MOH.
  • Based on the Price/Earnings ratio, MOH is valued cheaper than 84.16% of the companies in the same industry.
  • MOH's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.70.
  • MOH is valuated rather expensively with a Price/Forward Earnings ratio of 19.19.
  • The rest of the industry has a similar Price/Forward Earnings ratio as MOH.
  • When comparing the Price/Forward Earnings ratio of MOH to the average of the S&P500 Index (23.84), we can say MOH is valued inline with the index average.
Industry RankSector Rank
PE 14.01
Fwd PE 19.19
MOH Price Earnings VS Forward Price EarningsMOH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.64
MOH Per share dataMOH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MOH's earnings are expected to grow with 13.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.58%
EPS Next 3Y13.62%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MOH Dividend Analysis

5.1 Amount

  • MOH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MOH Fundamentals: All Metrics, Ratios and Statistics

MOLINA HEALTHCARE INC

NYSE:MOH (3/13/2026, 8:04:00 PM)

After market: 148.59 -0.61 (-0.41%)

149.2

+0.01 (+0.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05
Earnings (Next)04-22
Inst Owners105.33%
Inst Owner Change-7.91%
Ins Owners1.33%
Ins Owner Change10.61%
Market Cap7.68B
Revenue(TTM)45.43B
Net Income(TTM)472.00M
Analysts65
Price Target156.67 (5.01%)
Short Float %7.49%
Short Ratio2.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-484.67%
Min EPS beat(2)-916.01%
Max EPS beat(2)-53.34%
EPS beat(4)1
Avg EPS beat(4)-243.64%
Min EPS beat(4)-916.01%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-122.21%
EPS beat(12)7
Avg EPS beat(12)-79.46%
EPS beat(16)11
Avg EPS beat(16)-58.81%
Revenue beat(2)2
Avg Revenue beat(2)3.86%
Min Revenue beat(2)3.74%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)3.29%
Min Revenue beat(4)2.13%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)2.71%
Revenue beat(12)10
Avg Revenue beat(12)2.28%
Revenue beat(16)14
Avg Revenue beat(16)2.34%
PT rev (1m)-12.12%
PT rev (3m)-10.16%
EPS NQ rev (1m)-38.73%
EPS NQ rev (3m)-35.09%
EPS NY rev (1m)-44.06%
EPS NY rev (3m)-42.68%
Revenue NQ rev (1m)-5.1%
Revenue NQ rev (3m)-5.23%
Revenue NY rev (1m)-4%
Revenue NY rev (3m)-4.35%
Valuation
Industry RankSector Rank
PE 14.01
Fwd PE 19.19
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 1.89
P/tB 4.1
EV/EBITDA -0.64
EPS(TTM)10.65
EY7.14%
EPS(NY)7.78
Fwd EY5.21%
FCF(TTM)-12.35
FCFYN/A
OCF(TTM)-10.39
OCFYN/A
SpS882.06
BVpS79.01
TBVpS36.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number137.6
Profitability
Industry RankSector Rank
ROA 3.03%
ROE 11.6%
ROCE 9.57%
ROIC 7.39%
ROICexc N/A
ROICexgc N/A
OM 1.73%
PM (TTM) 1.04%
GM 13.07%
FCFM N/A
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.55%
ROCE(5y)20.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
F-Score4
Asset Turnover2.92
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA 4.03
Cap/Depr 51.79%
Cap/Sales 0.22%
Interest Coverage 4.33
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.69
Altman-Z 4.2
F-Score4
WACC7.92%
ROIC/WACC0.93
Cap/Depr(3y)51.56%
Cap/Depr(5y)53.03%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
Revenue Next Year0%
Revenue Next 2Y3.1%
Revenue Next 3Y3.89%
Revenue Next 5Y4.17%
EBIT growth 1Y-54.1%
EBIT growth 3Y-18.33%
EBIT growth 5Y-6.97%
EBIT Next Year-29.1%
EBIT Next 3Y6.7%
EBIT Next 5Y18.96%
FCF growth 1Y-216.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-183.07%
OCF growth 3YN/A
OCF growth 5YN/A

MOLINA HEALTHCARE INC / MOH Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?

ChartMill assigns a fundamental rating of 4 / 10 to MOH.


What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?

ChartMill assigns a valuation rating of 2 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Overvalued.


How profitable is MOLINA HEALTHCARE INC (MOH) stock?

MOLINA HEALTHCARE INC (MOH) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for MOH stock?

The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 14.01 and the Price/Book (PB) ratio is 1.89.